JP2023505190A5 - - Google Patents
Info
- Publication number
- JP2023505190A5 JP2023505190A5 JP2022533345A JP2022533345A JP2023505190A5 JP 2023505190 A5 JP2023505190 A5 JP 2023505190A5 JP 2022533345 A JP2022533345 A JP 2022533345A JP 2022533345 A JP2022533345 A JP 2022533345A JP 2023505190 A5 JP2023505190 A5 JP 2023505190A5
- Authority
- JP
- Japan
- Prior art keywords
- chain
- amino acid
- acid sequence
- insulin
- substitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944503P | 2019-12-06 | 2019-12-06 | |
| US62/944,503 | 2019-12-06 | ||
| PCT/US2020/062159 WO2021113136A1 (en) | 2019-12-06 | 2020-11-25 | Methods and compositions for the treatment and prevention of type 1 diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505190A JP2023505190A (ja) | 2023-02-08 |
| JP2023505190A5 true JP2023505190A5 (https=) | 2023-11-15 |
Family
ID=76222225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533345A Pending JP2023505190A (ja) | 2019-12-06 | 2020-11-25 | １型糖尿病の治療および予防のための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12551537B2 (https=) |
| EP (2) | EP4623900A3 (https=) |
| JP (1) | JP2023505190A (https=) |
| CN (1) | CN115151273A (https=) |
| AR (1) | AR122339A1 (https=) |
| AU (1) | AU2020398147A1 (https=) |
| CA (1) | CA3159054A1 (https=) |
| DK (1) | DK4069278T3 (https=) |
| FI (1) | FI4069278T3 (https=) |
| PL (1) | PL4069278T3 (https=) |
| TW (1) | TW202133876A (https=) |
| WO (1) | WO2021113136A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3159054A1 (en) * | 2019-12-06 | 2021-06-10 | Mary S. MORRIS | Methods and compositions for the treatment and prevention of type 1 diabetes |
| CN116847869A (zh) * | 2020-10-08 | 2023-10-03 | 美商玛丽莫里斯博士联合有限责任公司 | 用于治疗和预防1型糖尿病的方法和组合物 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5487898A (en) | 1991-08-26 | 1996-01-30 | Abbott Laboratories | Compositions and method for the sublingual or buccal administration therapeutic agents |
| EP1523993A1 (en) * | 1999-12-16 | 2005-04-20 | Eli Lilly & Company | Polypeptide compositions with improved stability |
| CN1409640A (zh) * | 1999-12-16 | 2003-04-09 | 伊莱利利公司 | 稳定性改善的多肽组合物 |
| CA2500715A1 (en) * | 2002-10-03 | 2004-04-15 | Epimmune Inc. | Hla binding peptides and their uses |
| PL1633876T3 (pl) * | 2003-06-17 | 2009-01-30 | Sembiosys Genetics Inc | Sposoby wytwarzania insuliny w roślinach |
| US20070027063A1 (en) | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
| EP1725254A4 (en) | 2004-02-04 | 2008-02-13 | Univ Columbia | ANTI-CD3 IMMUNOTHERAPY AND SPECIFIC ANTIGENS FOR THE TREATMENT OF AUTOIMMUNITY |
| US7279457B2 (en) | 2004-03-12 | 2007-10-09 | Biodel, Inc. | Rapid acting drug delivery compositions |
| US20090023630A1 (en) | 2005-01-31 | 2009-01-22 | Jan Wouter Drijfhout | Methods and Means for Use in Diagnostics and Treatment of Diabetes |
| AU2011202239C1 (en) * | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
| WO2012104834A1 (en) * | 2011-02-03 | 2012-08-09 | Pharmedica Ltd. | New oral dissolving films for insulin administration, for treating diabetes |
| JP2015514126A (ja) | 2012-04-16 | 2015-05-18 | アルク−アベッロ エイ／エスＡｌｋ−Ａｂｅｌｌｏ Ａ／Ｓ | 非特異的アレルギー免疫療法において使用するための植物プロフィリンポリペプチド |
| TW201625668A (zh) * | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物 |
| EP3215128B1 (en) * | 2014-11-04 | 2019-09-04 | Innopharmax, Inc. | Oral administration of unstable or poorly-absorbed drugs |
| US10905727B2 (en) | 2016-01-14 | 2021-02-02 | Intrexon Actobiotics N.V. | Compositions and methods for the treatment of type 1 diabetes |
| WO2018144867A1 (en) * | 2017-02-03 | 2018-08-09 | Vanderbilt University | Systems, compositions and methods for treating diabetes |
| EP3589271A4 (en) | 2017-02-28 | 2021-01-06 | Biolingus IP LLC | OIL BASED FORMULATIONS FOR SUBLINGUAL AND BUCCAL ADMINISTRATION |
| EP3418738A1 (en) | 2017-06-23 | 2018-12-26 | Klinikum rechts der Isar der Technischen Universität München | A ratio of immune cells as prognostic indicator of therapeutic success in allergen-specific immunotherapy |
| PL3954384T3 (pl) | 2017-09-08 | 2025-10-27 | Diamyd Medical Ab | Stratyfikacja genotypów w leczeniu i profilaktyce cukrzycy |
| CA3159054A1 (en) * | 2019-12-06 | 2021-06-10 | Mary S. MORRIS | Methods and compositions for the treatment and prevention of type 1 diabetes |
| CN116847869A (zh) | 2020-10-08 | 2023-10-03 | 美商玛丽莫里斯博士联合有限责任公司 | 用于治疗和预防1型糖尿病的方法和组合物 |
-
2020
- 2020-11-25 CA CA3159054A patent/CA3159054A1/en active Pending
- 2020-11-25 CN CN202080084253.5A patent/CN115151273A/zh active Pending
- 2020-11-25 JP JP2022533345A patent/JP2023505190A/ja active Pending
- 2020-11-25 EP EP25181562.7A patent/EP4623900A3/en active Pending
- 2020-11-25 WO PCT/US2020/062159 patent/WO2021113136A1/en not_active Ceased
- 2020-11-25 PL PL20896240.7T patent/PL4069278T3/pl unknown
- 2020-11-25 EP EP20896240.7A patent/EP4069278B1/en active Active
- 2020-11-25 FI FIEP20896240.7T patent/FI4069278T3/fi active
- 2020-11-25 AU AU2020398147A patent/AU2020398147A1/en active Pending
- 2020-11-25 DK DK20896240.7T patent/DK4069278T3/da active
- 2020-11-25 US US17/778,624 patent/US12551537B2/en active Active
- 2020-11-27 TW TW109141906A patent/TW202133876A/zh unknown
- 2020-11-30 AR ARP200103323A patent/AR122339A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1241942C (zh) | 使用胰岛素的肽类似物治疗糖尿病的方法 | |
| ES2799099T3 (es) | Proteínas de fusión | |
| ES2534434T3 (es) | Composiciones y métodos de uso de péptidos proislotes y análogos de los mismos | |
| JP4018116B2 (ja) | 新規アミリン作動薬ペプチドおよびその使用 | |
| AU2018338178B2 (en) | Glucagon-like peptide 1 receptor agonists and uses thereof | |
| DK2389388T3 (en) | TREATMENT FOR Obesity | |
| EP1515749B1 (en) | Combined use of a modulator of cd3 and a glp-1 compound | |
| TW201247702A (en) | Use of acylated glucagon analogues | |
| CA2434237A1 (en) | Glp-1 fusion proteins | |
| JP2010528092A (ja) | 代謝疾患の治療における治療剤としての非アシル化グレリン | |
| JP2025023996A (ja) | アシル化カルシトニン模倣体 | |
| JP2023505190A5 (https=) | ||
| JP2022513776A (ja) | インスリン受容体結合親和性が低下したインスリンアナログ | |
| KR102412114B1 (ko) | 제1형 당뇨병 자가면역에 대한 면역 조절 요법 | |
| KR970009353B1 (ko) | 초고활성 인체 인슐린 동족체 | |
| JPH10500109A (ja) | 多発性硬化症のための組成物および治療方法 | |
| JP7669339B2 (ja) | メタロチオネイン抗体およびそれらの使用 | |
| JP2023544832A5 (https=) | ||
| US11807672B2 (en) | Conjugates of islet neogenesis peptides and analogs, and methods thereof | |
| HUT70176A (en) | Amylin antagonists and agonists | |
| US6933274B2 (en) | Methods for treatment of diabetes using a peptide analogues of insulin | |
| AU781405B2 (en) | Methods for treatment of diabetes using peptide analogues of insulin | |
| EP0561130A1 (en) | Stabilized biologically active polypeptide and use thereof | |
| HK40016469A (en) | Composition | |
| HK40016469B (en) | Composition |